Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board

Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board

Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is one of the most important medical and social problems associated with significant risks for patients and a burden on the national healthcare system. There are significant unmet diagnostic and therapeutic needs of CKD in T2D patie...

Full description

Bibliographic Details
Main Authors: M. V. Shestakova, V. A. Dobronravov, A. S. Ametov, M. B. Antsiferov, M. M. Batyushin, I. N. Bobkova, G. R. Galstyan, T. Y. Demidova, V. V. Klimontov, A. M. Mkrtumyan, N. A. Petunina, E. I. Prokopenko, N. V. Chebotareva, M. S. Shamkhalova
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-11-01
Series:Сахарный диабет
Subjects:
finerenone
non-steroidal mineralocorticoid receptor antagonist
diabetes mellitus
chronic kidney disease
Online Access:https://www.dia-endojournals.ru/jour/article/view/13020

Internet

https://www.dia-endojournals.ru/jour/article/view/13020

Similar Items